Whitehawk Therapeutics, Inc 10-K for FY2024
Whitehawk Therapeutics, Inc. (WHWK)
10-K
2025-03-28
For: 2024-12-31
View Original
Added on
April 08, 2026
About this 10-K
Whitehawk Therapeutics, Inc filed this 10-K on March 28, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $25.98M
- up 6.7% from $24.35M a year earlier
- Net loss
- $63.69M
- compared with a net loss of $65.77M a year earlier
- Diluted EPS
- -$2.36
- compared with -$2.44 a year earlier